Fluorouracil and Oxaliplatin as First-line for Advanced Pancreatic Cancer

NCT02896803 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Neoplasms

Interventions

DRUG: mFLOX

Sponsor

Instituto do Cancer do Estado de São Paulo